07 Jul Patient diversity in clinical trials: How to meet the need
We need a new paradigm for increasing diversity in clinical trials....
We need a new paradigm for increasing diversity in clinical trials....
Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. With the right tools, sponsors can enhance the efficiency of trial execution, provide patients with new ways to participate in studies, and simplify collaboration with clinical sites....
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
Patients who participate in clinical trials win by benefiting from advancements discovered during previous trials as well as their own participation in successful studies. Doctors win by having more treatment options to offer their patients. Researchers win because clinical trials provide the opportunities they need...
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National Press Foundation Q&A....
Clinical trial diversity is garnering more attention from lawmakers as they seek to resolve a longstanding deficiency amid a larger national focus on health equity....
Obstacles exist, but the clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies....
It's been more than a week since COVID-19 vaccinations were approved for kids ages 6 months to 5 years old, but some hospitals are still waiting to schedule appointments....
Researchers estimate that COVID-19 vaccine shots prevented 1.9 million deaths in the United States during the first year they became available....
It’s probably time to remove the cookie-cutter mentality from your clinical trials operational tool kit....